Related Experiment Video

Updated: Aug 11, 2026

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups
10:35

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Published on: January 12, 2020

Persistent microvasculopathy in chronic eosinophilia-myalgia syndrome

S A Smith1

  • 1University of Minnesota, Hennepin Faculty Associates Neuromuscular Center, Minneapolis 55404, USA.

Advances in Experimental Medicine and Biology
|January 1, 1996
PubMed

Insights

Chronic eosinophilia-myalgia syndrome (EMS) involves persistent microvascular disease, unlike the acute phase. Biopsies reveal ongoing endothelial pathology and dysfunction years after L-tryptophan exposure.

Area of Science:

  • Pathology
  • Immunology
  • Neurology

Background:

  • Eosinophilia-myalgia syndrome (EMS) is a serious condition linked to contaminated L-tryptophan (LT) exposure.
  • Some individuals experience long-term symptoms including myalgia, fatigue, and cognitive issues, indicating a chronic form of the disease.

Purpose of the Study:

  • To investigate the pathological characteristics of chronic EMS.
  • To understand the long-term effects of LT exposure on affected tissues.

Main Methods:

  • Skin, fascia, and muscle biopsies were performed on 17 patients with chronic EMS symptoms.
  • Biopsies were analyzed four to five years after initial LT exposure and EMS onset.

Main Results:

  • All patients exhibited microvascular disease.
  • Lymphocytic inflammatory infiltrates were common, with some cases showing dermal sclerosis.
  • Eosinophil infiltration was rare in the chronic state, contrasting with acute EMS.

Conclusions:

  • Persistent microvascular disease is a hallmark of chronic EMS.
  • Endothelial pathology indicates ongoing microvascular dysfunction in long-term EMS.
  • Pathological findings in chronic EMS differ from acute EMS, particularly regarding eosinophil presence.

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis03:23

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis

Published on: May 10, 2024

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...